Form 8-K - Current report:
SEC Accession No. 0001628280-25-030804
Filing Date
2025-06-11
Accepted
2025-06-11 17:21:36
Documents
12
Period of Report
2025-06-11
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K aqst-20250611.htm   iXBRL 8-K 34037
  Complete submission text file 0001628280-25-030804.txt   148482

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aqst-20250611.xsd EX-101.SCH 1776
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aqst-20250611_lab.xml EX-101.LAB 21629
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aqst-20250611_pre.xml EX-101.PRE 12504
14 EXTRACTED XBRL INSTANCE DOCUMENT aqst-20250611_htm.xml XML 2719
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 251040933
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)